DK168007B1 - 1,9-disubstituerede 1,2,3,4-tetrahydrocarbazoler og farmaceutiske praeparater indeholdende saadanne forbindelser - Google Patents

1,9-disubstituerede 1,2,3,4-tetrahydrocarbazoler og farmaceutiske praeparater indeholdende saadanne forbindelser Download PDF

Info

Publication number
DK168007B1
DK168007B1 DK034287A DK34287A DK168007B1 DK 168007 B1 DK168007 B1 DK 168007B1 DK 034287 A DK034287 A DK 034287A DK 34287 A DK34287 A DK 34287A DK 168007 B1 DK168007 B1 DK 168007B1
Authority
DK
Denmark
Prior art keywords
chlorobenzyl
tetrahydrocarbazol
acetic acid
fluoro
compound
Prior art date
Application number
DK034287A
Other languages
Danish (da)
English (en)
Other versions
DK34287D0 (da
DK34287A (da
Inventor
Yvan Guindon
John Gillard
Christiane Yoakim
Original Assignee
Merck Frosst Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada Inc filed Critical Merck Frosst Canada Inc
Publication of DK34287D0 publication Critical patent/DK34287D0/da
Publication of DK34287A publication Critical patent/DK34287A/da
Application granted granted Critical
Publication of DK168007B1 publication Critical patent/DK168007B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK034287A 1986-01-23 1987-01-22 1,9-disubstituerede 1,2,3,4-tetrahydrocarbazoler og farmaceutiske praeparater indeholdende saadanne forbindelser DK168007B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82172686A 1986-01-23 1986-01-23
US82172686 1986-01-23

Publications (3)

Publication Number Publication Date
DK34287D0 DK34287D0 (da) 1987-01-22
DK34287A DK34287A (da) 1987-07-24
DK168007B1 true DK168007B1 (da) 1994-01-17

Family

ID=25234152

Family Applications (1)

Application Number Title Priority Date Filing Date
DK034287A DK168007B1 (da) 1986-01-23 1987-01-22 1,9-disubstituerede 1,2,3,4-tetrahydrocarbazoler og farmaceutiske praeparater indeholdende saadanne forbindelser

Country Status (14)

Country Link
EP (1) EP0234708B1 (fr)
JP (1) JPS62223169A (fr)
KR (1) KR870007117A (fr)
AT (1) ATE61047T1 (fr)
AU (1) AU592615B2 (fr)
DE (1) DE3768097D1 (fr)
DK (1) DK168007B1 (fr)
ES (1) ES2038653T3 (fr)
GR (1) GR3001828T3 (fr)
IE (1) IE59861B1 (fr)
IL (1) IL81325A (fr)
NZ (1) NZ218999A (fr)
PT (1) PT84178B (fr)
ZA (1) ZA87468B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808608A (en) * 1986-01-23 1989-02-28 Merck & Co., Inc. Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use
US4988820A (en) * 1986-02-21 1991-01-29 Bayer Aktiengesellschaft Cycloalkano(1,2-B) indole-sulponamides
AU633563B2 (en) * 1986-02-21 1993-02-04 Bayer Yakuhin, Ltd. Cycloalkanonesulphonamides
EP0239306B1 (fr) * 1986-03-27 1993-06-02 Merck Frosst Canada Inc. Esters de tétrahydrocarbazoles
US4940719A (en) * 1986-03-27 1990-07-10 Merck Frosst Canada, Inc. Tetrahydrocarbazole esters, pharmaceutical compositions and use
EP0307077A1 (fr) * 1987-07-21 1989-03-15 Merck Frosst Canada Inc. Tetrahydrocarbazoles pour une thérapie avec de la cyclosporine
GB8924392D0 (en) * 1989-10-30 1989-12-20 Bayer Ag Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides
GB9101375D0 (en) * 1991-01-22 1991-03-06 Erba Carlo Spa N-imidazolyl derivatives of substituted tetrahydrocarbazole and cyclohepht(b)indole
DE4435477A1 (de) * 1994-10-04 1996-04-11 Bayer Ag Cycloalkano-indol- und -azaindol-derivate
DE19615119A1 (de) 1996-04-17 1997-10-23 Bayer Ag Neue Arylessigsäureamide
DE19615265A1 (de) * 1996-04-18 1997-12-04 Bayer Ag Neue Pyridazino-, Pyrimido-, Pyrazino- und Triazino-indole
US6410583B1 (en) * 2000-07-25 2002-06-25 Merck Frosst Canada & Co. Cyclopentanoindoles, compositions containing such compounds and methods of treatment
AR038136A1 (es) 2002-01-24 2004-12-29 Merck Frosst Canada Inc Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento
EP1656141B1 (fr) * 2003-08-07 2010-04-14 MERCK SHARP & DOHME LTD. Procede pour traiter la maladie d'alzheimer et des pathologies liees
US7019022B2 (en) * 2003-12-15 2006-03-28 Merck Frosst Canada & Co. Substituted tetrahydrocarbazole and cyclopentanoindole derivatives
JP5841361B2 (ja) * 2011-06-29 2016-01-13 壽製薬株式会社 三環性化合物及びそれを含有する医薬組成物
US20230174485A1 (en) * 2020-03-25 2023-06-08 Sri International Lipoxygenase inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA715217B (en) * 1970-08-20 1972-04-26 Org Nv Anti-inflammatory preparations
AR205331A1 (es) * 1972-07-24 1976-04-30 Hoffmann La Roche Procedimiento para la preparacion de carbazoles
US4057559A (en) * 1973-10-01 1977-11-08 American Home Products Corporation Carbazole acetic acid derivatives
GB1511169A (en) * 1975-08-29 1978-05-17 American Home Prod Trycyclic acetic acid derivatives
US4616028A (en) * 1985-04-22 1986-10-07 American Home Products Corporation Substituted 2,3,4,9-tetrahydro-1H-carbazole-1-acetic acid derivatives, compositions and use

Also Published As

Publication number Publication date
DK34287D0 (da) 1987-01-22
DK34287A (da) 1987-07-24
ATE61047T1 (de) 1991-03-15
IL81325A0 (en) 1987-08-31
EP0234708A1 (fr) 1987-09-02
AU6790887A (en) 1987-07-30
GR3001828T3 (en) 1992-11-23
ZA87468B (en) 1987-08-26
DE3768097D1 (de) 1991-04-04
AU592615B2 (en) 1990-01-18
EP0234708B1 (fr) 1991-02-27
PT84178B (pt) 1990-06-29
PT84178A (pt) 1987-02-01
IL81325A (en) 1990-11-29
NZ218999A (en) 1990-12-21
ES2038653T3 (es) 1993-08-01
IE870168L (en) 1987-07-23
KR870007117A (ko) 1987-08-14
IE59861B1 (en) 1994-04-20
JPS62223169A (ja) 1987-10-01

Similar Documents

Publication Publication Date Title
DK168007B1 (da) 1,9-disubstituerede 1,2,3,4-tetrahydrocarbazoler og farmaceutiske praeparater indeholdende saadanne forbindelser
US4808608A (en) Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use
JP4008885B2 (ja) フルオロ置換シクロアルカノインドール及びそのプロスタグランジンｄ２受容体拮抗薬としての使用
US20010047027A1 (en) Prostaglandin D2 receptor antagonists
LU86406A1 (fr) Imidazoquinoleines antithrombogenes cardiotoniques
US4940719A (en) Tetrahydrocarbazole esters, pharmaceutical compositions and use
US4775680A (en) Cyclohept[b]indolealkanoic acids, pharmaceutical compositions and use
US8003670B2 (en) Aminoalkoxy aryl sulfonamide compounds and their use as 5-HT6 ligands
CA1299577C (fr) Acides tetrahydrocarbazole-1-alcanoiques
EP0239306B1 (fr) Esters de tétrahydrocarbazoles
US8318725B2 (en) Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligands
US4906654A (en) Cyclohept[b]indoleakanoic acids, pharmaceutical compositions and use
CA1326030C (fr) Acides cyclohept[b]indole alcanoiques
CA1305485C (fr) Acides tetrahydrocarbazole-1-alcanoiques
CA1330090C (fr) Esters de type tetrahydrocarbazole
AU2007203428B2 (en) Fluoro substituted cycloalkanoindoles and their use as prostaglandin D2 receptor antagonists

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed